ExodusPoint Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

ExodusPoint Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,308	Closed	-$771K	–	1802
2025 Q4	$771K	Sell	22,308 -33,055	-60%	-$1.05M	0.01%	1079
2025 Q3	$1.51M	Buy	55,363 +16,643	+43%	+$403K	0.02%	823
2025 Q2	$814K	Buy	+38,720	New	+$743K	0.01%	1020
2025 Q1	–	Sell	-52,252	Closed	-$1.34M	–	1712
2024 Q4	$1.34M	Sell	52,252 -343,236	-87%	-$9.72M	0.01%	852
2024 Q3	$12.5M	Buy	395,488 +118,690	+43%	+$4.5M	0.08%	197
2024 Q2	$9.72M	Buy	+276,798	New	+$11M	0.07%	260
2023 Q2	–	Sell	-24,330	Closed	-$334K	–	2033
2023 Q1	$334K	Buy	24,330 +13,380	+122%	+$223K	﹤0.01%	1447
2022 Q4	$199K	Buy	+10,950	New	+$184K	﹤0.01%	1461
2022 Q3	–	Sell	-13,099	Closed	-$181K	–	2078
2022 Q2	$181K	Sell	13,099 -53,196	-80%	-$592K	﹤0.01%	1676
2022 Q1	$742K	Buy	+66,295	New	+$977K	0.01%	1323
2020 Q3	–	Sell	-23,615	Closed	-$336K	–	1968
2020 Q2	$336K	Buy	+23,615	New	+$186K	0.01%	1260

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ExodusPoint Capital Management's IDYA Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 22,308 shares — an estimated $771K sold.

ExodusPoint Capital Management first reported a position in IDYA in Q2 2020 and held it in 11 quarters. The position peaked at $12.5M in Q3 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

ExodusPoint Capital Management reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 22,308 IDEAYA Biosciences shares in Q1 2026, an estimated $771K.
ExodusPoint Capital Management first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 11 quarters.
ExodusPoint Capital Management's IDEAYA Biosciences position peaked at $12.5M in Q3 2024.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.